The latest poultry, pig and animal feed news, animal agribusiness trends and research from WATTAgNet.com.
Thursday, July 9, 2015
Luoyang Huizhong Biotech invests in poultry vaccine lines
China’s Luoyang Huizhong Biotech Co. Ltd. has invested CNY150 million (US$24.5 million) to build six new vaccine production lines in the Luolong High Tech Industry Development Zone.
The production lines include a 100m mL capacity line for inactivated vero cell vaccines; a 200m dose capacity line for live vero cell vaccines; a 300m mL capacity line for inactivated poultry tissue vaccines; a 2bn dose capacity line for live poultry tissue vaccines; a 100m mL capacity line for inactivated bacterial vaccines; and a 100m dose capacity line for live bacterial vaccines, according a to report provided by Smart Agriculture Analytics.
Other facilities included in the company’s investment include a liquid and solid disinfectant workshop and warehouse, and a quality inspection center.
Luoyong Huizhong Biotech is involved in the research and production of new vaccines for veterinary use. It is a wholly owned subsidiary and private high-tech joint stock enterprise of Pulike Biological Engineering Inc. The company, according to its website, was founded in July 2011.